Keyword: Congress

Under a bipartisan opioid bill finalized by Congress, drugmakers will have to disclose payments made to nurses and physician assistants as well.

The drug industry has been seeking relief from a Medicare Part D change that'll cost the industry billions, but it came up short in a recent attempt.

After HHS proposed a rule that would shake up or eliminate drug rebates, a watchdog wants to know if agency chief Alex Azar has ulterior motives.

What do polarized senators dislike more than their partisan opponents? Pharma advertising, apparently.

If Novartis thought public statements this week would silence questions about its $1.2 million contract with Michael Cohen, it was wrong.

President Donald Trump's big speech on drug prices is set for Friday, but Democrats talked up their own proposals Thursday.

Pharma has suffered another defeat in the state-by-state war over drug prices.

PhRMA called new donut-hole drug discounts a "massive bailout" for payers, but the insurance lobby says pharma's arguments are "ridiculous."

Pharma suffered a blow in the Senate's budget deal, but how much will drugmakers really lose? Not a lot, on average, but some will take a bigger hit.

Sen. Sanders said it's time for Congress to force CEOs to testify on the opioid crisis as lawyers negotiate a potential settlement.